tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
AIM announces planned milestones in Phase 2 trial of Ampligen, Durvalumab
PremiumThe FlyAIM announces planned milestones in Phase 2 trial of Ampligen, Durvalumab
9d ago
AIM ImmunoTech announces commencement of rights offering
Premium
The Fly
AIM ImmunoTech announces commencement of rights offering
21d ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
23d ago
AIM ImmunoTech reports data in year-end update from Phase 2 trial of Ampligen
PremiumThe FlyAIM ImmunoTech reports data in year-end update from Phase 2 trial of Ampligen
27d ago
AIM ImmunoTech Inc trading resumes
Premium
The Fly
AIM ImmunoTech Inc trading resumes
1M ago
AIM ImmunoTech Inc trading halted, news pending
Premium
The Fly
AIM ImmunoTech Inc trading halted, news pending
1M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
2M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
AIM ImmunoTech Completes 2025 Annual Stockholder Meeting
Premium
Company Announcements
AIM ImmunoTech Completes 2025 Annual Stockholder Meeting
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100